BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25388867)

  • 1. In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.
    Ferreira PF; Kilner PJ; McGill LA; Nielles-Vallespin S; Scott AD; Ho SY; McCarthy KP; Haba MM; Ismail TF; Gatehouse PD; de Silva R; Lyon AR; Prasad SK; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 2014 Nov; 16(1):87. PubMed ID: 25388867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
    Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E
    Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    McGill LA; Ismail TF; Nielles-Vallespin S; Ferreira P; Scott AD; Roughton M; Kilner PJ; Ho SY; McCarthy KP; Gatehouse PD; de Silva R; Speier P; Feiweier T; Mekkaoui C; Sosnovik DE; Prasad SK; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):86. PubMed ID: 23259835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance.
    Nielles-Vallespin S; Khalique Z; Ferreira PF; de Silva R; Scott AD; Kilner P; McGill LA; Giannakidis A; Gatehouse PD; Ennis D; Aliotta E; Al-Khalil M; Kellman P; Mazilu D; Balaban RS; Firmin DN; Arai AE; Pennell DJ
    J Am Coll Cardiol; 2017 Feb; 69(6):661-676. PubMed ID: 28183509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying Dynamic Myofiber Aggregate Reorientation in Dilated Cardiomyopathy Using In Vivo Magnetic Resonance Diffusion Tensor Imaging.
    von Deuster C; Sammut E; Asner L; Nordsletten D; Lamata P; Stoeck CT; Kozerke S; Razavi R
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):e005018. PubMed ID: 27729361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
    J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing dynamic myocardial microstructure with cardiac magnetic resonance diffusion tensor imaging.
    Axel L; Wedeen VJ; Ennis DB
    J Cardiovasc Magn Reson; 2014 Nov; 16(1):89. PubMed ID: 25388937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy.
    Satriano A; Heydari B; Guron N; Fenwick K; Cheung M; Mikami Y; Merchant N; Lydell CP; Howarth AG; Fine NM; White JA
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1913-1924. PubMed ID: 31144257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight Into Myocardial Microstructure of Athletes and Hypertrophic Cardiomyopathy Patients Using Diffusion Tensor Imaging.
    Das A; Chowdhary A; Kelly C; Teh I; Stoeck CT; Kozerke S; Maxwell N; Craven TP; Jex NJ; Saunderson CED; Brown LAE; Ben-Arzi H; Sengupta A; Page SP; Swoboda PP; Greenwood JP; Schneider JE; Plein S; Dall'Armellina E
    J Magn Reson Imaging; 2021 Jan; 53(1):73-82. PubMed ID: 32558016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.
    Brouwer WP; Baars EN; Germans T; de Boer K; Beek AM; van der Velden J; van Rossum AC; Hofman MB
    J Cardiovasc Magn Reson; 2014 Apr; 16(1):28. PubMed ID: 24766828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing cardiomyocyte mobility with multi-phase cardiac diffusion tensor MRI.
    Moulin K; Verzhbinsky IA; Maforo NG; Perotti LE; Ennis DB
    PLoS One; 2020; 15(11):e0241996. PubMed ID: 33180823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.